Approximately 8.75 million people are living with type 1 diabetes
ADA Scientific Sessions showcase innovations and guidance for early risk monitoring of type 1 diabetesResearch presented highlights the benefits of CGM metrics in predicting the progression and risk of the condition.
> Read more